The European multicenter trial on the safety and efficacy of guided oblique lumbar interbody fusion (GO-LIF)

<p>Abstract</p> <p>Background</p> <p>Because of the implant-related problems with pedicle screw-based spinal instrumentations, other types of fixation have been tried in spinal arthrodesis. One such technique is the direct trans-pedicular, trans-discal screw fixation, p...

Full description

Bibliographic Details
Main Authors: Birkenmaier Christof, Suess Olaf, Pfeiffer Michael, Burger Ralf, Schmieder Kirsten, Wegener Bernd
Format: Article
Language:English
Published: BMC 2010-09-01
Series:BMC Musculoskeletal Disorders
Online Access:http://www.biomedcentral.com/1471-2474/11/199
_version_ 1818261961650995200
author Birkenmaier Christof
Suess Olaf
Pfeiffer Michael
Burger Ralf
Schmieder Kirsten
Wegener Bernd
author_facet Birkenmaier Christof
Suess Olaf
Pfeiffer Michael
Burger Ralf
Schmieder Kirsten
Wegener Bernd
author_sort Birkenmaier Christof
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>Because of the implant-related problems with pedicle screw-based spinal instrumentations, other types of fixation have been tried in spinal arthrodesis. One such technique is the direct trans-pedicular, trans-discal screw fixation, pioneered by Grob for spondylolisthesis. The newly developed GO-LIF procedure expands the scope of the Grob technique in several important ways and adds security by means of robotic-assisted navigation. This is the first clinical trial on the GO-LIF procedure and it will assess safety and efficacy.</p> <p>Methods/Design</p> <p>Multicentric prospective study with n = 40 patients to undergo single level instrumented spinal arthrodesis of the lumbar or the lumbosacral spine, based on a diagnosis of: painful disc degeneration, painful erosive osteochondrosis, segmental instability, recurrent disc herniation, spinal canal stenosis or foraminal stenosis. The primary target criteria with regards to safety are: The number, severity and cause of intra- and perioperative complications. The number of significant penetrations of the cortical layer of the vertebral body by the implant as recognized on postoperative CT. The primary target parameters with regards to feasibility are: Performance of the procedure according to the preoperative plan. The planned follow-up is 12 months and the following scores will be evaluated as secondary target parameters with regards to clinical improvement: VAS back pain, VAS leg pain, Oswestry Disability Index, short form - 12 health questionnaire and the Swiss spinal stenosis questionnaire for patients with spinal claudication. The secondary parameters with regards to construct stability are visible fusion or lack thereof and signs of implant loosening, implant migration or pseudarthrosis on plain and functional radiographs.</p> <p>Discussion</p> <p>This trial will for the first time assess the safety and efficacy of guided oblique lumbar interbody fusion. There is no control group, but the results, the outcome and the rate of any complications will be analyzed on the background of the literature on instrumented spinal fusion. Despite its limitations, we expect that this study will serve as the key step in deciding whether a direct comparative trial with another fusion technique is warranted.</p> <p>Trial Registration</p> <p>Clinical Trials NCT00810433</p>
first_indexed 2024-12-12T18:55:33Z
format Article
id doaj.art-5788a922b9db4a25a9a2bf85ea8ffa9e
institution Directory Open Access Journal
issn 1471-2474
language English
last_indexed 2024-12-12T18:55:33Z
publishDate 2010-09-01
publisher BMC
record_format Article
series BMC Musculoskeletal Disorders
spelling doaj.art-5788a922b9db4a25a9a2bf85ea8ffa9e2022-12-22T00:15:16ZengBMCBMC Musculoskeletal Disorders1471-24742010-09-0111119910.1186/1471-2474-11-199The European multicenter trial on the safety and efficacy of guided oblique lumbar interbody fusion (GO-LIF)Birkenmaier ChristofSuess OlafPfeiffer MichaelBurger RalfSchmieder KirstenWegener Bernd<p>Abstract</p> <p>Background</p> <p>Because of the implant-related problems with pedicle screw-based spinal instrumentations, other types of fixation have been tried in spinal arthrodesis. One such technique is the direct trans-pedicular, trans-discal screw fixation, pioneered by Grob for spondylolisthesis. The newly developed GO-LIF procedure expands the scope of the Grob technique in several important ways and adds security by means of robotic-assisted navigation. This is the first clinical trial on the GO-LIF procedure and it will assess safety and efficacy.</p> <p>Methods/Design</p> <p>Multicentric prospective study with n = 40 patients to undergo single level instrumented spinal arthrodesis of the lumbar or the lumbosacral spine, based on a diagnosis of: painful disc degeneration, painful erosive osteochondrosis, segmental instability, recurrent disc herniation, spinal canal stenosis or foraminal stenosis. The primary target criteria with regards to safety are: The number, severity and cause of intra- and perioperative complications. The number of significant penetrations of the cortical layer of the vertebral body by the implant as recognized on postoperative CT. The primary target parameters with regards to feasibility are: Performance of the procedure according to the preoperative plan. The planned follow-up is 12 months and the following scores will be evaluated as secondary target parameters with regards to clinical improvement: VAS back pain, VAS leg pain, Oswestry Disability Index, short form - 12 health questionnaire and the Swiss spinal stenosis questionnaire for patients with spinal claudication. The secondary parameters with regards to construct stability are visible fusion or lack thereof and signs of implant loosening, implant migration or pseudarthrosis on plain and functional radiographs.</p> <p>Discussion</p> <p>This trial will for the first time assess the safety and efficacy of guided oblique lumbar interbody fusion. There is no control group, but the results, the outcome and the rate of any complications will be analyzed on the background of the literature on instrumented spinal fusion. Despite its limitations, we expect that this study will serve as the key step in deciding whether a direct comparative trial with another fusion technique is warranted.</p> <p>Trial Registration</p> <p>Clinical Trials NCT00810433</p>http://www.biomedcentral.com/1471-2474/11/199
spellingShingle Birkenmaier Christof
Suess Olaf
Pfeiffer Michael
Burger Ralf
Schmieder Kirsten
Wegener Bernd
The European multicenter trial on the safety and efficacy of guided oblique lumbar interbody fusion (GO-LIF)
BMC Musculoskeletal Disorders
title The European multicenter trial on the safety and efficacy of guided oblique lumbar interbody fusion (GO-LIF)
title_full The European multicenter trial on the safety and efficacy of guided oblique lumbar interbody fusion (GO-LIF)
title_fullStr The European multicenter trial on the safety and efficacy of guided oblique lumbar interbody fusion (GO-LIF)
title_full_unstemmed The European multicenter trial on the safety and efficacy of guided oblique lumbar interbody fusion (GO-LIF)
title_short The European multicenter trial on the safety and efficacy of guided oblique lumbar interbody fusion (GO-LIF)
title_sort european multicenter trial on the safety and efficacy of guided oblique lumbar interbody fusion go lif
url http://www.biomedcentral.com/1471-2474/11/199
work_keys_str_mv AT birkenmaierchristof theeuropeanmulticentertrialonthesafetyandefficacyofguidedobliquelumbarinterbodyfusiongolif
AT suessolaf theeuropeanmulticentertrialonthesafetyandefficacyofguidedobliquelumbarinterbodyfusiongolif
AT pfeiffermichael theeuropeanmulticentertrialonthesafetyandefficacyofguidedobliquelumbarinterbodyfusiongolif
AT burgerralf theeuropeanmulticentertrialonthesafetyandefficacyofguidedobliquelumbarinterbodyfusiongolif
AT schmiederkirsten theeuropeanmulticentertrialonthesafetyandefficacyofguidedobliquelumbarinterbodyfusiongolif
AT wegenerbernd theeuropeanmulticentertrialonthesafetyandefficacyofguidedobliquelumbarinterbodyfusiongolif
AT birkenmaierchristof europeanmulticentertrialonthesafetyandefficacyofguidedobliquelumbarinterbodyfusiongolif
AT suessolaf europeanmulticentertrialonthesafetyandefficacyofguidedobliquelumbarinterbodyfusiongolif
AT pfeiffermichael europeanmulticentertrialonthesafetyandefficacyofguidedobliquelumbarinterbodyfusiongolif
AT burgerralf europeanmulticentertrialonthesafetyandefficacyofguidedobliquelumbarinterbodyfusiongolif
AT schmiederkirsten europeanmulticentertrialonthesafetyandefficacyofguidedobliquelumbarinterbodyfusiongolif
AT wegenerbernd europeanmulticentertrialonthesafetyandefficacyofguidedobliquelumbarinterbodyfusiongolif